日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives

验证天然化合物作为 Toll 样受体 4 (TLR4) 拮抗剂的有效性:实验挑战和治疗前景

Lami, Federico; Romerio, Alessio; Valle-Gómez, Laura; Martín-Cámara, Olmo; Martín-Santamaría, Sonsoles; Peri, Francesco

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge

基于单糖的合成TLR4激动剂可增强疫苗对铜绿假单胞菌感染的效力

Sainz-Mejías, Maite; Ma, Chaoying; Hou, Yueran; Jurado-Martin, Irene; Romerio, Alessio; Franco, Ana Rita; Shaik, Mohammed Monsoor; Tomás-Cortázar, Julen; Peri, Francesco; McClean, Siobhán

Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists.

迈向更高效的合成免疫调节剂:单糖衍生的 TLR4 激动剂的生物学特性和作用机制

Franco Ana Rita, Aladailleh Zaineh, Romerio Alessio, Italia Alice, Lami Federico, Shaik Mohammed Monsoor, Skupinska Natalia, Artusa Valentina, Pirianov Grisha, Peri Francesco

Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection

TLR4拮抗剂FP12作为靶向HMGB1/MD-2/TLR4轴治疗致命性流感感染的先导药物,正在进行临床前开发。

Shirey, Kari Ann; Romerio, Alessio; Shaik, Mohammed Monsoor; Leake, David S; Palmer, Charys; Skupinska, Natalia; Paton, Jules; Pirianov, Grisha; Blanco, Jorge Cg; Vogel, Stefanie N; Peri, Francesco

Selective SERCA2a activator as a candidate for chronic heart failure therapy

选择性SERCA2a激活剂作为慢性心力衰竭治疗的候选药物

Arici, Martina; Hsu, Shih-Che; Ferrandi, Mara; Barassi, Paolo; Ronchi, Carlotta; Torre, Eleonora; Luraghi, Andrea; Chang, Gwo-Jyh; Ferrari, Patrizia; Bianchi, Giuseppe; Peri, Francesco; Zaza, Antonio; Rocchetti, Marcella

Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant

基于合成TLR4激动剂FP20和合成QS-21变体的组合开发一种新型疫苗佐剂系统

Shaik, Mohammed Monsoor; Pasco, Samuel; Romerio, Alessio; Pifferi, Carlo; Sesana, Silvia; Re, Francesca; Bezuidenhout, Charl Xavier; Bracco, Silvia; Fernandez-Tejada, Alberto; Anguita, Juan; Peri, Francesco

A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice

一种小分子TLR4拮抗剂可减轻雌性E4FAD小鼠的神经炎症。

Balu, Deebika; Valencia-Olvera, Ana C; Nguyen, Austin; Patnam, Mehul; York, Jason; Peri, Francesco; Neumann, Frank; LaDu, Mary Jo; Tai, Leon M

Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory

肠道菌群衍生的天然产物靶向癌症干细胞:肠道制药工厂内部探秘

Artusa, Valentina; Calabrone, Luana; Mortara, Lorenzo; Peri, Francesco; Bruno, Antonino

Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection

针对耐药结核分枝杆菌感染的创新药理学方法:新兴的细胞外分子靶点

Italia, Alice; Shaik, Mohammed Monsoor; Peri, Francesco

Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity

克服化学糖基化难题,获得具有增强的TLR4活性的创新型疫苗佐剂

Romerio, Alessio; Franco, Ana Rita; Shadrick, Melanie; Shaik, Mohammed Monsoor; Artusa, Valentina; Italia, Alice; Lami, Federico; Demchenko, Alexei V; Peri, Francesco